NCT04033991 Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib. Status COMPLETED Phase N/A
NCT04032756 Tofacitinib Registry of Patients With Ulcerative Colitis in Germany Status TERMINATED Phase N/A
NCT04032093 A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN Status COMPLETED Phase PHASE2
NCT04029480 Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059) Status COMPLETED Phase PHASE3
NCT04023084 Response of Children With Atopic Dermatitis (Eczema) to Eucrisa Status COMPLETED Phase PHASE4
NCT04018274 Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids Status COMPLETED Phase PHASE1
NCT04018001 Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR) Status COMPLETED Phase N/A
NCT04016077 A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of PF-06651600 in Subjects With Hepatic Impairment and Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04008784 Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period Status COMPLETED Phase N/A
NCT04004663 Bioavailability Study of PF-06651600 Formulations in Healthy Participants Status COMPLETED Phase PHASE1
NCT04002830 A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease Status COMPLETED Phase PHASE4
NCT03992781 Changes of Depression After First-year of Tofacitinib in RA Patients Status COMPLETED Phase N/A
NCT03991884 Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1
NCT03990896 Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial Status RECRUITING Phase PHASE2
NCT03985293 A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT03981900 IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT03978143 Evaluate Taste and Relative Bioavailability of Two Microsphere Formulations of Crizotinib in Healthy Participants Status COMPLETED Phase PHASE1